UNSPSC 51281502: Isoniazid

This classification denotes an antitubercular agent with the molecular formula C6H7N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V83O1VOZ8L, chemically known as 4-pyridinecarboxylic acid, hydrazide but generally known as isoniazid, which bears US NIH Compound Identifier 3767. European Medicines Agency schedules Isoniazid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08326MIG. The term ISONIAZID is an International Non-Proprietary Name.

UNSPSC 51281502 Isoniazid, a Commodity code, covers pharmaceutical products procured by state and local health agencies, though recent opportunities tagged under this code show limited activity aligned with its nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a three-year term via IFB. State and local buying under this code appears concentrated among health departments and county public health agencies procuring antibiotics and related pharmaceutical products for stockpile, emergency preparedness, or community health distribution. The issuing bodies represent state-level health departments and county health authorities, with cooperative purchasing vehicles such as MMCAP Infuse serving as the contracting mechanism.

Recent activity centers in Illinois and Florida, though the dataset supports limited geographic spread. Seminole County, Florida issued an IFB in June 2026 (response due July 26, 2023, a date discrepancy in the source) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building; this procurement, potentially FEMA-funded, required electronic bidding, drug-free workplace certification, and E-Verify compliance. The Illinois contract represents the more substantial recent opportunity by contract value and duration. Neither opportunity explicitly required set-aside designations or disadvantaged-enterprise preferences. The code shows sparse recent activity overall, and opportunities posted under it diverge notably from isoniazid-specific procurement — most recent tagged opportunities address broader pharmaceutical products or naloxone-related community health supplies rather than isoniazid specifically.